Hiroyuki Miyachi

Design, synthesis, and structural analysis of phenylpropanoic acid-type PPARγ-selective agonists: discovery of reversed stereochemistry-activity relationship.

Shuichi Hirono, Yuichi Hashimoto, Masao Ohashi, 2011, Journal of medicinal chemistry.

Angiogenesis inhibitors derived from thalidomide.

Hiroko Sano, Yuichi Hashimoto, Y. Hashimoto, 2005, Bioorganic & medicinal chemistry letters.

Peroxisome proliferator-activated receptors (PPARs) have multiple binding points that accommodate ligands in various conformations: phenylpropanoic acid-type PPAR ligands bind to PPAR in different conformations, depending on the subtype.

Naoyuki Kuwabara, Toshiyuki Shimizu, Masao Ohashi, 2012, Journal of medicinal chemistry.

Design and synthesis of a series of α-benzyl phenylpropanoic acid-type peroxisome proliferator-activated receptor (PPAR) gamma partial agonists with improved aqueous solubility.

Kenji Matsuno, Masao Ohashi, K. Matsuno, 2013, Bioorganic & medicinal chemistry.

Involvement of the Retinoid X Receptor Ligand in the Anti-Inflammatory Effect Induced by Peroxisome Proliferator-Activated Receptor γ Agonist In Vivo

Yukio Sugimoto, H. Miyachi, Hiroyuki Miyachi, 2011, PPAR research.